A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Clinical trial NCT07038369 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07038369
Sponsor: Atavistik Bio, Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Breast Cancer Breast Carcinoma Breast Neoplasms ER Positive Breast Cancer Cervical Cancers Cervical Neoplasms Cervical Carcinoma Triple Negative Breast Cancer Gynecologic Cancers Gynecologic Neoplasm Endometrial Cancer

Start date: 2025-07-29
Primary completion: 2028-08-31
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.